IFFGD has been working with the International Working Group for the Classification of Oesophagitis (IWGCO) to create a survey to better understand the illness experience of those with Refractory Gastroesophageal Reflux Disease (rGERD). Refractory Gastroesophageal Reflux Disease (rGERD) is very common and may affect up to 40% of people who use a proton pump inhibitor (PPI) once daily. Most individuals using a PPI are doing so for the treatment of Gastroesophageal Reflux Disease (GERD). GERD is a condition where stomach contents flow back (reflux) into the esophagus (the muscular tube that connects the mouth and the stomach, allowing food to pass into the stomach). (remove) Heartburn and/or regurgitation are common symptoms associated with GERD. Most people describe heartburn as a burning sensation behind the breastbone in their chest that may radiate towards their neck and throat. GERD is treated with lifestyle modification, weight loss, and medications, such as proton pump inhibitors (PPIs). Using a PPI can be an effective and cost-effective way to manage your GERD symptoms. However, in some people, PPI therapy and lifestyle changes are not enough to control symptoms. When there is persistence of symptoms despite treatment, the diagnosis is rGERD.
You can participate in this survey here.